We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck, AstraZeneca, Cornerstone Update Asthma Drug Warnings
Merck, AstraZeneca, Cornerstone Update Asthma Drug Warnings
August 28, 2009
Merck, AstraZeneca and Cornerstone Therapeutics have added warnings about psychiatric effects to the labels of their leukotriene-modifier asthma drugs about two months after the FDA requested the change.